stella
beta
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers — Stella
Recruiting
Back to Gastric Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Beijing Cancer Hospital, Beijing, Beijing Municipality
View full record on ClinicalTrials.gov